Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Shares Outstanding (Diluted Average) (2016 - 2023)

Ekso Bionics Holdings has reported Shares Outstanding (Diluted Average) over the past 11 years, most recently at $13.3 million for Q1 2023.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 4.46% to $13.3 million in Q1 2023 year-over-year; TTM through Mar 2023 was $13.3 million, a 4.46% increase, with the full-year FY2022 number at $13.0 million, up 5.65% from a year prior.
  • Shares Outstanding (Diluted Average) reached $13.3 million in Q1 2023 per EKSO's latest filing, up from $13.0 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $13.3 million in Q1 2023, with the low at $5.0 million in Q3 2019.
  • The 5-year median for Shares Outstanding (Diluted Average) is $12.7 million (2021), against an average of $10.6 million.
  • Peak YoY movement for Shares Outstanding (Diluted Average): tumbled 91.77% in 2019, then surged 111.16% in 2021.
  • Tracing EKSO's Shares Outstanding (Diluted Average) over 5 years: stood at $5.0 million in 2019, then soared by 43.37% to $7.2 million in 2020, then surged by 71.26% to $12.3 million in 2021, then increased by 5.65% to $13.0 million in 2022, then rose by 2.58% to $13.3 million in 2023.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $13.3 million, $13.0 million, and $13.1 million for Q1 2023, Q4 2022, and Q3 2022 respectively.